Related references
Note: Only part of the references are listed.Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era
Giordano Madeddu et al.
AIDS (2021)
Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis
Anita Mesic et al.
AIDS RESEARCH AND THERAPY (2021)
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study
Lucia Taramasso et al.
AIDS PATIENT CARE AND STDS (2021)
Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa
Helen Bell Gorrod et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART
Lucas E. Hermans et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
Amir Shroufi et al.
AIDS (2019)
Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response
Paul K. Drain et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Alison J. Rodger et al.
LANCET (2019)
Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis
Dumessa Edessa et al.
PLOS ONE (2019)
Bias in the estimation of cumulative viremia in cohort studies of HIV-infected individuals
Maia Lesosky et al.
ANNALS OF EPIDEMIOLOGY (2019)
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naive patients: results from a multicenter cohort study
Barbara Rossetti et al.
ANTIVIRAL RESEARCH (2019)
Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis
Mario Cruciani et al.
PLOS ONE (2019)
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)
Lucia Taramasso et al.
AIDS RESEARCH AND THERAPY (2019)
HIV-1 heterosexual transmission and association with sexually transmitted infections in the era of treatment as prevention
Marineide Goncalves de Melo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis
Nathan Ford et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study
Serge P. Eholie et al.
LANCET HIV (2019)
Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study
Khine Khine Thinn et al.
BMJ OPEN (2019)
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
Lucas E. Hermans et al.
LANCET INFECTIOUS DISEASES (2018)
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
Benjamin R. Bavinton et al.
LANCET HIV (2018)
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Steve Kanters et al.
LANCET HIV (2017)
Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort
Joseph B. Sempa et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges
Teri Roberts et al.
CLINICAL INFECTIOUS DISEASES (2016)
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
Alison J. Rodger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
John Gregson et al.
LANCET INFECTIOUS DISEASES (2016)
The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study
Janne Estill et al.
LANCET HIV (2016)
Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa
Julia K. Rohr et al.
PLOS ONE (2016)
Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care
Gary Marks et al.
AIDS (2015)
Boosted Lopinavir- Versus Boosted Atazanavir-Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries
Lauren E. Cain et al.
CLINICAL INFECTIOUS DISEASES (2015)
Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy
Stephen T. Wright et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings
Mina C. Hosseinipour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
Olawale Ajose et al.
AIDS (2012)
Is operational research delivering the goods? The journey to success in low-income countries
Rony Zachariah et al.
LANCET INFECTIOUS DISEASES (2012)
Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy
Michael J. Mugavero et al.
CLINICAL INFECTIOUS DISEASES (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS
Vincent C. Marconi et al.
PLOS ONE (2011)
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Annemarie M. J. Wensing et al.
ANTIVIRAL RESEARCH (2010)
Inflammation and Complications of HIV Disease
Michael P. Dube et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Cumulative HIV Viremia during Highly Active Antiretroviral Therapy Is a Strong Predictor of AIDS-Related Lymphoma
Alexander Zoufaly et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial
W. M. El-Sadr et al.
ANNALS OF INTERNAL MEDICINE (2008)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)